NCT01872065View on ClinicalTrials.gov

Safety and Tolerability Study of ARC-520 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

September 30, 2014

Study Completion Date

November 30, 2014

Conditions
Healthy
Interventions
DRUG

ARC-520

DRUG

Placebo

Trial Locations (1)

3004

Nucleus Network Ltd., Melbourne

Sponsors
All Listed Sponsors
lead

Arrowhead Pharmaceuticals

INDUSTRY